TRCT
SVNT

Tower Research Capital (TRC)’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Tower Research Capital (TRC)’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,923
Closed -$1K – 5445
2013
Q3 		$1K Buy
+1,923
New +$1.23K ﹤0.01% 4476

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Tower Research Capital (TRC)'s SVNT Position: Q4 2013 in Review

Tower Research Capital (TRC) sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 1,923 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in SVNT in Q3 2013 and held it in 1 quarter. The position peaked at $1K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Tower Research Capital (TRC) reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,923 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in SAVIENT PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s SAVIENT PHARMACEUTICALS INC position peaked at $1K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.